Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Paraneoplastic syndromes, defined in this book as ""disorders caused by cancer, but not a direct result of cancer invasion of the affected organ or tissue"", once believed to be rare and esoteric neurologic disorders have assumed increasing importance as an

Paraneoplastic syndromes.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Neoplasms --- Paraneoplastic Endocrine Syndromes --- complications

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

HYPERCALCEMIA --- HYPERPARATHYROIDISM --- PARANEOPLASTIC SYNDROMES --- VITAMIN D --- COMPLICATIONS --- HYPERCALCEMIA --- HYPERPARATHYROIDISM --- PARANEOPLASTIC SYNDROMES --- VITAMIN D --- COMPLICATIONS

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Features "Endocrine-Related Cancer," a journal published by the Society for Endocrinology in Bristol, England. Offers access to browsable abstracts, as well as the full-text of current and previous issues. Contains information about investigations into endocrine-related cancer in humans and animals

Endocrine System Diseases --- Hormones --- Neoplastic Endocrine-Like Syndromes --- adverse effects --- periodicals. --- therapeutic use --- Endocrine glands --- Endocrine System Diseases. --- Neoplasms. --- Diseases --- Cancer --- adverse effects. --- therapeutic use. --- Cancer. --- Diseases. --- Society for Endocrinology. --- Bristol (England) --- Great Britain. --- England --- Paraneoplastic Endocrine Syndromes. --- Ectopic Hormone Syndromes --- Ectopic Hormone Syndrome --- Endocrine Syndrome, Paraneoplastic --- Paraneoplastic Endocrine Syndrome --- Syndrome, Ectopic Hormone --- Syndrome, Paraneoplastic Endocrine --- Syndromes, Ectopic Hormone --- Syndromes, Paraneoplastic Endocrine --- Hormones, Ectopic --- Diseases of Endocrine System --- Endocrine Diseases --- Disease, Endocrine --- Disease, Endocrine System --- Diseases, Endocrine --- Diseases, Endocrine System --- Endocrine Disease --- Endocrine System Disease --- System Disease, Endocrine --- System Diseases, Endocrine --- Endocrinology --- Periodicals --- Health Sciences --- Life Sciences --- Clinical Medicine --- Oncology --- Metabolism --- Clinical endocrinology --- Endocrine diseases --- Hormonal disorders --- Ductless glands --- Gland of internal secretion --- Glands, Ductless --- Anglia --- Angliyah --- Briṭanyah --- Grande-Bretagne --- Grossbritannien --- Marea Britanie --- Nagy-Britannia --- Prydain Fawr --- Royaume-Uni --- Saharātchaʻānāčhak --- Storbritannien --- United Kingdom --- United Kingdom of Great Britain and Ireland --- United Kingdom of Great Britain and Northern Ireland --- Velikobritanii︠a︡ --- Wielka Brytania --- Bristol --- Bristol, Eng. --- Corporation of the City of Bristol (England) --- Bristol (Avon) --- City of Bristol (England) --- City and County of Bristol (England) --- City & County of Bristol (England) --- Bristol (England : Unitary authority) --- Paraneoplastic Endocrine Syndromes --- Glands --- Chromaffin cells --- Northern Ireland --- Scotland --- Wales --- Hormone --- Hormone Receptor Agonists --- Agonists, Hormone Receptor --- Receptor Agonists, Hormone --- Endocrine Glands --- Great Britain --- England and Wales --- Velikobritanii͡ --- Förenade kungariket --- Grã-Bretanha --- Igirisu --- Iso-Britannia --- Yhdistynyt kuningaskunta --- Neoplastic Endocrine-Like Syndromes. --- Endocrine Gland Neoplasms. --- Endocrine Glands. --- United Kingdom.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Apheresis refers to an extracorporeal therapy which aims at removing pathological constituents from the patients’ blood. Due to the development of new techniques as well as the discovery of novel autoimmune antibodies, it is increasingly recognized as an important therapeutic option for a variety of autoimmune-mediated neurological disorders, including multiple sclerosis, myasthenia gravis, autoimmune encephalitis, Guillain–Barré syndrome, and many others. Therapeutic plasma exchange (TPE) constitutes the standard method of apheresis for most indications, while immunoadsorption (IA) offers a more specific, low-risk alternative. Both methods aim at removing auto-antibodies from the blood. Evidence for most neurological diseases is still low. Interestingly, more recent developments suggest that apheresis is not limited to the removal of autoantibodies but may also be useful in neurodegenerative and possibly even in acute vascular disorders.

immunoadsorption --- acute relapsing multiple sclerosis --- plasma exchange --- therapeutic apheresis --- multiple sclerosis --- optic neuritis --- relapse --- class IV --- steroids --- Alzheimer’s clinical syndrome --- dementia --- autoantibodies --- α1-Adrenergic receptor --- Inflammatory neuropathy --- chronic inflammatory demyelinating polyneuropathy --- Guillain-Barré syndrome --- paranodal antibodies --- plasmapheresis --- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome --- ß2 adrenoreceptor autoantibody --- autoimmune encephalitis --- limbic encephalitis --- NMDAR (N-Methyl-D-Aspartat) --- antibody --- paraneoplastic --- apheresis --- therapeutic plasma exchange --- neurological diseases --- CRP --- stroke --- inflammation --- n/a --- Alzheimer's clinical syndrome --- Guillain-Barré syndrome